Neovasc Inc. EPS (Basic, from Continuous Ops)

EPS (Basic, from Continuous Ops) of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including EPS (Basic, from Continuous Ops) growth rates and interactive chart.


Highlights and Quick Summary

  • EPS (Basic, from Continuous Ops) for the quarter ending March 31, 2022 was -3.75 (a 41.92% increase compared to previous quarter)
  • Year-over-year quarterly EPS (Basic, from Continuous Ops) increased by 12.03%
  • Annual EPS (Basic, from Continuous Ops) for 2021 was -9.88 (a -77.04% decrease from previous year)
  • Annual EPS (Basic, from Continuous Ops) for 2020 was -43.04 (a -68.09% decrease from previous year)
  • Annual EPS (Basic, from Continuous Ops) for 2019 was -134.87 (a -92.93% decrease from previous year)
  • Twelve month EPS (Basic, from Continuous Ops) ending March 31, 2022 was -12.52 (a 26.72% increase compared to previous quarter)
  • Twelve month trailing EPS (Basic, from Continuous Ops) decreased by -29.56% year-over-year
Trailing EPS (Basic, from Continuous Ops) for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
-12.52 -9.88 -7.73 -17.78
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EPS (Basic, from Continuous Ops) of Neovasc Inc.

Most recent EPS (Basic, from Continuous Ops)of NVCN including historical data for past 10 years.

Interactive Chart of EPS (Basic, from Continuous Ops) of Neovasc Inc.

Neovasc Inc. EPS (Basic, from Continuous Ops) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -3.75
2021 -2.64 -2.79 -3.35 -1.11 -9.88
2020 -0.49 -12.83 -20.31 -9.41 -43.04
2019 -31.43 -20.67 -29.19 -53.58 -134.87
2018 -700.95 -194.22 -914.85 -96.47 -1906.49
2017 -1353.02 -1487.95 -1693.91 -2492.34 -7027.22
2016 14208.29 -10893.09 -31295.79 -4071.19 -32051.77
2015 -2734.82 -2832.22 -2537.29 -2006.54 -10218.54
2014 -2753.18 -1841.82 -2689.55 -181.58 -8211.93
2013 -1131.05 -729.47 -637.37 -1025.56 -3451.05
2012 1915.26 -673.33 -834.44 -701.67 -2751.67
2011 -582.94 -2297.65

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.